Article

Victoza® LEAD Clinical Trial Program

Victoza® studies included nearly 4000 patients in the Liraglutide Effect and Action in Diabetes (LEAD) trials. Click here for more information.

Related Videos
Image credit: Photo18@desing | stock.dobe.com
Image credit: JJAVA | stock.adobe.com
Genetic engineering and gene manipulation concept. Hand is replacing part of a DNA molecule - Image credit: vchalup | stock.adobe.com
Related Content
Next-generation sequencing | Image Credit: © Supaporn - stock.adobe.com
April 30th 2025

Biomarker Testing Transforms NSCLC Care, But Gaps Persist in Community Settings

Alexandra Gerlach, Associate Editor
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
March 31st 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
National Stress Awareness Month Is Here
April 30th 2025

National Stress Awareness Month Is Here

Jennifer Gershman, PharmD, CPh, PACS
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Blue FDA approval stamp -- Image credit: B-design | stock.adobe.com
April 29th 2025

FDA Approves Upadacitinib for Adult Patients With Giant Cell Arteritis

Gillian McGovern, Associate Editor
Take Charge of Hypertension: Essential Steps for Better Health
April 29th 2025

Take Charge of Hypertension: Essential Steps for Better Health

Melissa Russo, PharmD